Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Factor VIII inhibitor epitope mapping in previously treated hemophilia A patients
2004-000219-24Phase 4Completed
- Sponsor
- Wyeth
- Start
- Apr 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of recombinant human coagulation factor VIII, Factor VIII, octocog alfa and coagulation factor VIII (human) in hemophilia A, sponsored by Wyeth. Started Apr 2005; status: completed.
02
Drugs
recombinant human coagulation factor VIIIFactor VIIIoctocog alfacoagulation factor VIII (human)
03
Conditions
hemophilia A
Beyond the preview
Go deeper on 2004-000219-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000219-24.